0R3M Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vivoryon Therapeutics NV

Watchlist Manager

Watchlist

Price: 1.185 EUR -6.69%

Market Cap: €35.1m

	Vivoryon Therapeutics NV LSE:0R3M	DE
T	Tokai Holdings Corp TSE:3167	JP
U	Union Pacific Corp F:UNP	US
	Phillips 66 NYSE:PSX	US
	Bidvest Group Ltd OTC:BDVSY	ZA
	NIO Inc BMV:NION	CN
	Juniper Networks Inc NYSE:JNPR	US
	BCE Inc TSX:BCE	CA
C	Cashbuild Ltd XBER:C8J	ZA
J	JSR Corp SWB:JYR	JP
I	Iss A/S SWB:QJQ	DK

Profitability Summary

Vivoryon Therapeutics NV's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Sustainable 3Y Average Gross Margin

43%

Low Operating Margin

Strong 3Y Average Operating Margin

840%

Low Net Margin

Strong 3Y Average Net Margin

822%

Healthy Free Cash Flow Margin

Strong 3Y Average Free Cash Flow Margin

508%

Negative ROE

-145%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

2.009%

Declining ROIC

-3.165% > -3.588%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.